Nov. 2023 Podcasts: Australia-China uneasy partnership, end for value investing
A Reluctant Embrace: The Australia-China Uneasy Partnership
In this podcast, Nucleus Wealth's Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, revisited the tense relations with our largest trading partner.
Prime Minister Albanese is in China this week. The Australia-China trade relationship has been fraught with tension, stemming from a complex interplay of geopolitical rivalry, human rights concerns, and security issues. Australia’s push for an inquiry into the origins of COVID-19, and its outspoken criticism of China’s actions in Hong Kong and Xinjiang, led to diplomatic strains, with China retaliating by imposing tariffs and import restrictions on key Australian exports like barley, wine, and beef.
Furthermore, China’s increasing assertiveness in the South China Sea and its economic coercion tactics have triggered a defensive response from Australia, leading to calls for diversification of trade partnerships and a reevaluation of reliance on the Chinese market. The once mutually beneficial economic ties now face the challenges of trust deficit and ideological clashes, complicating the prospects of smooth trade relations.
Watch the episode here.
Is It The End For Value Investing?
The last few year’s of performance suggests there are some serious problems with value investing. In recent weeks, share market volatility has re-emerged, and many investors are expecting Value to protect them – but Value has failed to do so in recent years. Will this time be any different?
In this podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen and Head of Advice, Samuel Kerr take a hard look at the problems with Value investing and what investors should expect.
Watch the episode here.
Agenda
- How is value performing (spoiler: bad)
- What is value
- What went wrong
- Have we got measurement error
- How I think about value
Why Is Excess Mortality Still High, What Does It Mean For Insurers?
Years after the COVID-19 pandemic has subsided, excess mortality is still way higher than usual in countries all around the world.
Suicides, cancer, COVID-19 and heart disease are all running above average.
In this podcast, Nucleus Wealth's Chief Investment Officer, Damien Klassen, delves into what that means for life insurers and broader investments.
Agenda:
- Excess Deaths: Background
- Over and under
- Insurers. Hit hard, but not terrible. Now repricing.
- Obesity drugs: Background
- Why
- How
- When
Watch the episode here.
The Weight Is Over: Capitalising on the Booming Weight Loss Drug Industry
In this podcast, Nucleus Wealth’s Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr delve into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics.
We provide an in-depth analysis of the top players in the industry, including established pharmaceutical giants and innovative startups that are shaking up the scene. We explore the efficacy and safety of these booming weight loss drugs, what new treatments are on the horizon and how to profit from this trend.
Watch the episode here.
An Investor’s Guide to 3rd Quarter Earnings
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, delve into the complex landscape of 3rd quarter earnings.
The overall trend shows a downgrade in earnings forecasts, signalling a cautious approach by many companies. However, amidst this general downtrend, there exists a noteworthy exception – a group dubbed “The Magnificent 7”. These stocks have not only defied the broader market sentiment but have also showcased remarkable resilience and growth potential.
As we dissect these earnings reports, we observe that the market, while grappling with immediate uncertainties, continues to hold a surprisingly optimistic outlook for 2024. This optimism seems rooted in the belief that current challenges are temporary and that a stronger economic environment is on the horizon.
Watch the episode here.
5 topics